Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A2B trial of antibiotic prophylaxis for excision-graft surgery in adult burn patients
2024-514349-13-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2020
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in burn injury comparing Cefazolin prophylaxis, Piperacillin + tazobactam prophylaxis and Placebo control (3 arms). Planned start Oct 2020; status: authorised.
02
Drugs
cefazolinpiperacillin + tazobactam
03
Conditions
burn injury
Beyond the preview
Go deeper on 2024-514349-13-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514349-13-00.